VoxCell BioInnovation

VoxCell BioInnovation is advancing the future of in vitro modeling. We develop 3D bioprinted, vascularized human-like tissue models that closely replicate native biology, offering a powerful tool for more predictive, physiologically relevant research. Leveraging our proprietary high-resolution bioprinter, advanced vascularization software, and Universal Bioinks™, we produce complex tissue models that mirror patient biopsy samples in structure and function. Our flagship product is a 3D vascularized model of Triple Negative Breast Cancer (TNBC), designed to support applications in disease modeling, drug screening, vascular toxicity, and targeted delivery. Delivered as ready-to-use, perfusable models, VoxCell’s consumable products serve pharmaceutical companies, biotech firms, CROs, and academic researchers seeking to reduce translational gaps and accelerate biomedical innovation.